XML 164 R63.htm IDEA: XBRL DOCUMENT v3.25.1
Accounts Payable, Accrued Expenses and Other Current Liabilities, and Other Long-Term Liabilities - Schedule of Accounts Payable, Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Jan. 31, 2025
Jul. 31, 2024
Jul. 31, 2023
Accounts payable, accrued expenses and other current liabilities:      
Accrued litigation fee, current $ 500,000 [1] $ 750,000 [1],[2] [2]
Investment securities payable 69,621
Others 943 137,436  
Total 500,943 957,057  
Current portion of long-term payables:      
Accrued litigation fee, noncurrent $ 250,000 [1] $ 250,000 [1],[2] [2]
[1] On September 24, 2024, the Company and Boustead Securities, LLC (“Boustead”) entered into a settlement agreement, pursuant to which the Company would compensate Boustead in the amount of $1,000,000. The compensation is payable in three instalments, with first instalment of $250,000 payable with execution of settlement agreement, the second instalment of $500,000 payable before March 1, 2025, and the final instalment of $250,000 payable before December 31, 2025. In September 2024, the Company paid the first instalment. Accordingly, the Company recorded accrued litigation fees of $500,000 and $750,000 as current liabilities as of January 31, 2025 and July 31, 2024, respectively. The remaining $250,000 was recorded as noncurrent liabilities as of January 31, 2025 and July 31, 2024.
[2] On September 24, 2024, the Company and Boustead Securities, LLC (“Boustead”) entered into a settlement agreement, pursuant to which the Company would compensate Boustead in the amount of $1,000,000 (Note 14). The compensation is payable in three instalments, with first instalment of $250,000 payable with execution of settlement agreement, the second instalment of $500,000 payable before March 1, 2025, and the final instalment of $250,000 payable before December 31, 2025. Accordingly, the Company recorded accrued litigation fees of $750,000 as current liabilities, and the remaining $250,000 as noncurrent liabilities.